Pharmaceutical Composition

Details for Australian Patent Application No. 2003228612 (hide)

Owner Bentley Pharmaceuticals, Inc.

Inventors Gyurik, Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2003228612

PCT Number PCT/US03/12235

PCT Pub. Number WO2003/088974

Priority 60/374,103 19.04.02 US

Filing date 21 April 2003

Wipo publication date 3 November 2003

Acceptance publication date 4 May 2006

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/374,103 19.04.02 US

11 December 2003 Application Open to Public Inspection

  Published as AU-B-2003228612

4 May 2006 Application Accepted

  Published as AU-B-2003228612

31 August 2006 Standard Patent Sealed

4 December 2008 Assignment Registered

  Bentley Pharmaceuticals, Inc. The patent has been assigned to CPEX Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228613-ACRYLIC RELEASE AGENT PRECURSOR, RELEASE AGENT ARTICLE, AND PROCESS FOR PRODUCING RELEASE AGENT ARTICLE

2003228611-EMITTER WITH FILLED ZEOLITE EMISSION LAYER